Oxford’s vaccine won’t be available in US until mid-2021 if FDA waits for trial end – Times of India

Jenner Institute Director Adrian Hill, who oversees the Oxford-AstraZeneca COVID-19 vaccine research and development, told NBC News that if the US Food and Drug Administration waits for the end of their vaccine trial, the vaccine would not be available in the US until “the middle of next year.”
“That’s too late to take the value of this vaccine, which is effective, available at large scale and easily deployed,” he said in remarks tweeted by NBC News on Wednesday.

Source link

About news

Check Also

At least one fighter killed in US air strikes on Iran-backed militias in Syria – Times of India

BAGHDAD: US air strikes against Iran-backed militias in eastern Syria killed at least one fighter …

Leave a Reply

Your email address will not be published. Required fields are marked *